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Background/introduction
Background: In the absence of randomised study data
institutional series have shown High Intensity Focused
Ultrasound (HIFU) to produce excellent overall and can-
cer specific survival rates in patients with localized pros-
tate cancer (LPCa) compared with alternative curative
treatments.
Objectives: To evaluate the oncologic outcome of
patients treated with HIFU versus conformal external beam
radiation therapy (C-EBRT) without previous or associated
androgen deprivation (AD). This study is designed to over-
come limitations of case series studies by using a matched
pair design in patients treated contemporaneously with
HIFU and C-EBRT in two institutions in the same town.
Methods
Design, setting and participants: 256 eligible patients with
intermediate risk prostate cancer (d’Amico classification)
treated between 2000 and 2005 were prospectively fol-
lowed and matched to a 1:1 basis following know prognos-
tic variables: prostate-specific antigen (PSA) level and
Gleason score. 190 perfect matches of patients (95 in each
group) were further analysed. Progression free survival
rate were the primary endpoint. Other endpoints were sec-
ondary used of salvage therapy, and survival rate without
salvage palliative androgen deprivation therapy (S-ADT).
The progression free survival rates were calculated with
Kaplan-Meier estimate. For progression free calculation,
failure was defined using the Phoenix definition (nadir +
2ng/ml) or at the time of a salvage treatment for local
relapse evidenced by control biopsy.
Results and conclusions
Results: The seven years progression free survival rate was
not significantly different after HIFU than after C-EBRT
(47% versus 52%, p: 0.311). The palliative androgen depri-
vation free rate at seven years was significantly different
after HIFU than after C-EBRT (85% versus 58%, p: 0.002).
Conclusion: The progression free survival rate was not sig-
nificantly different after HIFU use than after C-EBRT but the
rate of patients who need palliative S-ADT was significantly
different after HIFU or C-EBRT: Higher rate of S-ADT was
associated with C-EBRT use than with HIFU use.
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